Table 1 Distribution of patients according to demographic features, clinico-laboratory data, O2 requirements, and therapy
Demographic features (N-%) | Clinical data (N-%) | Laboratory profile (N-%) | O2 status and needs (N-%) | ||||
|---|---|---|---|---|---|---|---|
• Age | • Duration (time interval) | • D-dimer | • O2 saturation at room air | ||||
- <45 | 18 (24.7%) | - 2nd week | 20 (27.4%) | - Normal | 6 (8.2%) | - 80%: < 93% | 55 (75.3%) |
- ≥45 | 55 (75.3%) | - 3rd week | 22 (30.1%) | - High without PE | 43 (58.9%) | - < 80% | 18 (24.7%) |
- Mean ± SD | 53.3 ± 13.5 | - 4th week | 28 (38.4%) | - High with PE | 24 (32.9%) | • O2 requirements: | |
- (Min.–Max.) | (18–88) | - 2nd month | 3 (4.1%) | - Mean | 1574.1 | - High flow nasal O2: | 58 (79.5%) |
- SD | 1392.2 | - Mechanical ventilation: | 15 (21.5%) | ||||
• Sex | • Symptoms | • CRP | |||||
- Male | 53 (72.6%) | - Dyspnea | 63 (86.3%) | - Normal | 7 (9.6%) | ||
- Female | 20 (27.4%) | - Fever | 61 (83.6%) | - High | 66 (90.4%) | ||
- Cough | 54 (74%) | - Mean | 7.8 | ||||
- Chest pain | 8 (11%) | - SD | 7.3 | ||||
- GIT-related | 16 (21.9%) | • Lymphocytic count | |||||
• Lung co-morbidities | - Normal | 3 (4.1%) | |||||
- Asthma | 4 (66.7%) | - Low | 70 (95.9%) | ||||
- Emphysema | 2 (33.3%) | ||||||
• General co-morbidities | |||||||
- Hypertension | 32 (43.8%) | ||||||
- Diabetes | 25 (34.2%) | ||||||
- Lymphoma | 1 (1.4%) | ||||||